Zura Bio Limited (ZURA) Financials
ZURA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 213.4 million | 16.3 million |
| March 31, 2026 | 228.6 million | 11.7 million |
| Dec. 31, 2025 | 113.9 million | 12.4 million |
| Sept. 30, 2025 | 143.9 million | 25.5 million |
ZURA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -20.9 million | 4.5 million |
| March 31, 2026 | -18.9 million | 5.0 million |
| Dec. 31, 2025 | -22.3 million | 2.6 million |
| Sept. 30, 2025 | -15.5 million | 2.4 million |
ZURA Net Income
No data available :(
ZURA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 205.1 million | - | - |
| March 31, 2026 | 225.6 million | - | - |
| Dec. 31, 2025 | 109.4 million | - | - |
| Sept. 30, 2025 | 139.0 million | - | - |
ZURA Shares Outstanding
ZURA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 24000 | 20.7 million | 8.6 million | - |
| March 31, 2026 | 13000 | 14.7 million | 10.8 million | - |
| Dec. 31, 2025 | 17000 | 11.0 million | 7.5 million | - |
| Sept. 30, 2025 | 31999 | 11.9 million | 7.6 million | - |
ZURA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 16000 |
| Dec. 31, 2025 | - | 15000 |
| Sept. 30, 2025 | - | 14000 |
ZURA
Price: $5.75
52 week price:
Earnings Per Share: -1.12 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 559.6 million